Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression

Genes to Cells

Volumn 13, Issue 2, 2008, Pages 131-144

  Sato, Fuyuki ^a   Bhawal, Ujjal Kumar ^b   Kawamoto, Takeshi ^c   Fujimoto, Katsumi ^c   Imaizumi, Tadaatsu ^a   Imanaka, Tadanobu ^d   Kondo, Jun ^a   Koyanagi, Satoru ^e   Noshiro, Mitsuhide ^c   Yoshida, Hidemi ^a   Kusumi, Tomomi ^a   Kato, Yukio ^c   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HETERODIMER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DEC1; TRANSCRIPTION FACTOR DEC2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARTILAGE; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HYPOXIA; IMMUNOPRECIPITATION; MALE; NONHUMAN; OSCILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SARCOMA CELL; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL HYPOXIA; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SARCOMA 180; TRANSCRIPTION FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38849110894     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2007.01153.x     Document Type: Article

References (33)

1. Ben-Av, P., Crofford, L.J., Wilder, R.L. & Hla, T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83-87.
2. Boudjelal, M., Taneja, R., Matsubara, S., Bouillet, P., Dolle, P. & Chambon, P. (1997) Overexpression of stra13, a novel retinoic acid-inducible gene of the basic-helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 11, 2052-2065.
3. Chakrabarti, J., Turley, H., Campo, L., Han, C., Harris, A.L., Gatter, K.C. & Fox, S.B. (2004) The transcriptional factor DEC1 (stra13, Sharp2) is associated with the hypoxic response and high tumor grade in human breast cancers. Br. J. Cancer 91, 954-958.
4. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. & Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
5. Fujimoto, K., Hamaguchi, H., Hashiba, T., Nakamura, T., Kawamoto, T., Sato, F., Noshiro, M., Bhawal, U.K., Suardita, K., & Kato, Y. (2007) Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Int. J. Mol. Med. 19, 925-932.
6. Furukawa, M., Kawamoto, T., Noshiro, M., Honda, K.K., Sakai, M., Fujimoto, K., Honma, S., Honma, K., Hamada, T. & Kato, Y. (2005) Clock gene expression in the submandibular glands. J. Dent. Res. 84, 1193-1197.
7. Gery, S., Komatsu, N., Baldjyan, L., Yu, A., Koo, D. & Koeffler, H.P. (2006) The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell 22, 375-382.
8. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M. & Reme, C.E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718-724.
9. Hamaguchi, H., Fujimoto, K., Kawamoto, T., Noshiro, M., Maemura, K., Takeda, N., Nagai, R., Furukawa, M., Honma, S., Honma, K., Kurihara, H. & Kato, Y. (2004) Expression of the gene for Dec 2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem. J. 382, 43-50.
10. Hlatky, L., Tsionou, C., Hahnfeldt, P. & Coleman, C.N. (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res. 54, 6083-6086.
11. Honma, S., Kawamoto, T., Takagi, Y., Fujimoto, K., Sato, F., Noshiro, M., Kato, Y. & Honma, K. (2002) Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419, 841-844.
12. Ishibashi, H., Shiratuchi, T., Nakagawa, K., Onimaru, M., Sugiura, T., Sueishi, K. & Shirasuna, K. (2001) Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol. 37, 77-83.
13. Ivanov, S.V., Salnikow, K., Ivanova, A.V., Bai, L. & Lerman, M.I. (2007) Hypoxic repression of STAT1 and its downstream genes by a pVHL/ HIF-1 target DEC1/STRA13. Oncogene 26, 802-812.
14. Ivanova, A.V., Ivanov, S.V., Danilkovitch-Miagkova, A. & Lerman, M.I. (2001) Regulation of stra13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J. Biol. Chem. 276, 15306-15315.
15. Jiang, B.H., Rue, E., Wang, G.L., Roe, R. & Semenza, G.L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778.
16. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. & Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
17. Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acqisto, F., Addeo, R., Makuuchi, M. & Esumi, H. (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189-197.
18. Kini, A.R., Peterson, L.A., Tallman, M.S. & Lingen, M.W. (2001) Angiogenesis in acute promyelocytic leukemia: Induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 97, 3919-3924.
19. Kondo, J., Sato, F., Fujimoto, K., Kusumi, T., Imanaka, T., Kawamoto, T., Bhawal, U.K., Noshiro, M., Kato, Y., Sato, T. & Kijima, H. (2006) 57Arg in the bHLH transcription factor DEC2 is essential for the suppression of CLOCK/BMAL2-mediated transactivation. Int. J. Mol. Med. 17, 1053-1056.
20. Koyanagi, S., Kuramoto, Y., Nakagawa, H., Aramaki, H., Ohdo, S., Soeda, S. & Shimeno, H. (2003) A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 63, 7277-7283.
21. Li, J., Perrella, M.A., Tsai, J.C., Yet, S.F., Hsieh, C.M., Yoshizumi, M., Patterson, C., Endege, W.O., Zhou, F. & Lee, M.E. (1995) Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270, 308-312.
22. Li, Y., Xie, M., Song, X., Gragen, S., Sachdeva, K., Wan, Y. & Yan, B. (2003) DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J. Biol. Chem. 278, 16899-16907.
23. Miyazaki, K., Kawamoto, T., Tanimoto, K., Nishiyama, M., Honda, H. & Kato, Y. (2002) Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J. Biol. Chem. 277, 47014-47021.
24. Noshiro, M., Kawamoto, T., Furukawa, M., Fujimoto, K., Yoshida, Y., Sasabe, E., Tsutsumi, S., Hamada, T., Honma, S., Honma, K. & Kato, Y. (2004) Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP. Genes Cells 9, 317-329.
25. Qin, C., Wilson, C., Blancher, C., Taylor, M., Safe, S. & Harris, A.L. (2001) Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. Clin. Cancer Res. 7, 818-823.
26. Sangoram, A.M., Saez, L., Antoch, M.P., Gekakis, N., Staknis, D., Whiteley, A., Fruechte, E.M., Vitaterna, M.H., Shimomura, K., King, D.P., Young, M.W., Weitz, C.J. & Takahashi, J.S. (1998) Mammalian circadian autoregulatory loop: A timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription. Neuron 21, 1101-1113.
27. Sato, F., Imaizumi, T., Sashinami, H., Yoshida, H., Kusumi, T., Mori, F., Wakabayashi, K., Nakane, A., Satoh, K. & Kijima, H. (2007) Upregulation of vascular endothelial growth factor by heat-killed Listeria monocytogenes in macrophages. Biochem. Biophys. Res. Commun. 354, 608-612.
28. Sato, F., Kawamoto, T., Fujimoto, K., Noshiro, M., Honda, K.K., Honma, S., Honma, K. & Kato, Y. (2004) Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation. Interaction with BMAL1. Eur. J. Biochem. 271, 4409-4419.
29. Shen, M., Kawamoto, T., Yan, W., Nakamasu, K., Tamagami, M., Koyano, Y., Noshiro, M. & Kato, Y. (1997) Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem. Biophys. Res. Commun. 236, 294-298.
30. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
31. Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Symes, J.F. & Isner, J.M. (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670.
32. Yeh, C.T., Lu, S.C., Tseng, I.C., Lai, H.Y., Tsao, M.L., Huang, S.F. & Liaw, Y.F. (2003) Antisense overexpression of BMAL2 enhances cell proliferation. Oncogene 22, 5306-5314.
33. Yun, Z., Maecker, H.L., Johnson, R.S. & Giaccia, A.J. (2002) Inhibition of PPAR2. Oncogene 22, 5306-5314.